Therapy News and Research

RSS

Femta files IND with FDA for FM101 monoclonal antibody against RA

Femta Pharmaceuticals announced today that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate a clinical development program for FM101, a high-affinity, humanized monoclonal antibody against Interleukin-6 (IL-6), in patients with rheumatoid arthritis (RA).

1 Aug 2011

Auxilium second quarter net loss decreases to $5.1 million

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended June 30, 2011. For the second quarter of 2011, Auxilium reported net revenues of $65.9 million compared to net revenues of $50.5 million in the second quarter of 2010.

1 Aug 2011

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) recently granted approval to the company's Mallinckrodt business for morphine sulfate oral solution, used to relieve moderate to severe acute and chronic pain in opioid-tolerant patients. The solution will be available as a generic in 100 milligrams per 5 mL (20 milligrams per 1 mL).

1 Aug 2011

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist Pharmaceuticals, Inc. today announced the initiation of a pivotal Phase 3 trial of CXA-201 in patients with complicated urinary tract infections.

1 Aug 2011

PathoGenetiX receives $4.0 million in first close of Series B financing

PathoGenetiX Inc., today announced that the Company has received $4.0 million in the first closing of its Series B financing.

1 Aug 2011

Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions

Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with unmet medical needs, presented its lead clinical candidate, Bendavia, during the 2011 American Heart Association's (AHA) Cardiovascular Scientific Sessions.

1 Aug 2011

Tips for obtaining life insurance after heart attack

Life Quotes, Inc. wants heart attack survivors to know that, while it may be tough to get a life insurance policy, it's not impossible. Heart disease is the #1 cause of death in America and many survivors are unaware of the life insurance options that may be open to them.

1 Aug 2011

Accuray to showcase CyberKnife, TomoTherapy systems at AAPM/COMP meeting

Accuray Incorporated, the premier radiation oncology company, announced today that it will showcase the CyberKnife Robotic Radiosurgery System and the TomoTherapy Radiation Therapy Treatment System in the company's booths at the 2011 Joint American Association of Physicists in Medicine (AAPM)/Canadian Organization of Medical Physicists (COMP) Meeting.

1 Aug 2011

Nursing homes attack Medicare's payment cuts

"Medicare says it will cut payments to nursing homes to correct for an unintended windfall this year, and the industry is warning that quality will be compromised. Officials announced the 11 percent cut Friday, along with other changes meant to tamp down on physical therapy costs".

1 Aug 2011

Universal flu vaccine based on “super antibody” coming soon

Researchers have finally found the first antibody which can fight all types of the influenza A virus. The results of the experiments on flu-infected mice, published in Science Express, showed the antibody could be used as an “emergency treatment” for flu as well.

31 Jul 2011

UT Southwestern's support group book shares stories of members whose wives battled cancer

When a loved one has cancer, it affects the entire family. For men, many of whom are less likely to take advantage of a support group, this can leave a void with devastating emotional consequences.

30 Jul 2011

Demonstrators in Swaziland express concern over possible antiretroviral shortages

More than 3,000 demonstrators gathered across Swaziland on Thursday for a second day of protests over the king's handling of an economic crisis that they say is causing a shortage of medical supplies, including antiretroviral therapy, the Associated Press/Washington Post reports (7/28).

30 Jul 2011

Alliance for Quality Nursing Home Care expresses alarm about CMS' newly-published Final Rule

Saying the nation's Skilled Nursing Facility sector has contributed significantly to advancing health care reform and deficit reduction in the face of severe state Medicaid funding pressures and other major budgetary challenges, the Alliance for Quality Nursing Home Care today expressed alarm about the Centers for Medicare and Medicaid Services' newly-published Final Rule ["Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities for FY 2012"], and said it will dangerously destabilize the nation's second largest health facility employer, place patients and their care at deep risk, and put tens of thousands of health jobs in immediate jeopardy.

30 Jul 2011

RegenoCELL to open new facility in Panama for treatment of congestive heart failure

RegenoCELL Therapeutics, Inc., a leader in adult stem cell therapy, is pleased to announce it is planning to open another state of the art facility in Panama for patients to be treated for congestive heart failure and peripheral artery disease with its autologous stem cell therapy.

30 Jul 2011

Lupin, Lilly partner to promote and distribute Huminsulin products in India and Nepal

Eli Lilly India and Lupin Limited today announced they have entered into a strategic collaboration to promote and distribute Lilly's Huminsulin range of products, including Huminsulin R, Huminsulin NPH, Huminsulin 50/50, Huminsulin 30/70 and Humapen Ergo II.

30 Jul 2011

Caltech researchers find simple engineering technique to ward off HIV

If one is good, two can sometimes be better. Researchers at the California Institute of Technology (Caltech) have certainly found this to be the case when it comes to a small HIV-fighting protein.

30 Jul 2011

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

30 Jul 2011

Therapy News and Research

Femta files IND with FDA for FM101 monoclonal antibody against RA

Auxilium second quarter net loss decreases to $5.1 million

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

PathoGenetiX receives $4.0 million in first close of Series B financing

Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions

Tips for obtaining life insurance after heart attack

Accuray to showcase CyberKnife, TomoTherapy systems at AAPM/COMP meeting

Nursing homes attack Medicare's payment cuts

Universal flu vaccine based on “super antibody” coming soon

UT Southwestern's support group book shares stories of members whose wives battled cancer

Demonstrators in Swaziland express concern over possible antiretroviral shortages

Alliance for Quality Nursing Home Care expresses alarm about CMS' newly-published Final Rule

RegenoCELL to open new facility in Panama for treatment of congestive heart failure

Lupin, Lilly partner to promote and distribute Huminsulin products in India and Nepal

Caltech researchers find simple engineering technique to ward off HIV

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

Varian Medical Systems signs agreement with CIVCO to offer Body Pro-Lok to its customers

UH Rainbow physicians to participate in two new clinical trials with AsthmaNet

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News